Bluejay Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing ...

WHO’s classification of hepatitis D virus as carcinogenic raises urgent questions for vaccination, screening, and treatment ...

Bluejay Therapeutics Announces Data Presentations in Chronic Hepatitis D (CHD) and Chronic Hepatitis B (CHB) at Upcoming American Association for the Study of Liver Diseases (AASLD) The Liver ...

Medical experts say vaccination is the best prevention method for hepatitis B, a liver infection that can be acute or chronic ...

President Donald Trump has come out against the infant dose of hepatitis B vaccine. It could split the GOP and their MAHA agenda.

It's unusual for presidents to give medical advice. But this week, President Trump told parents to delay giving their kids a ...

Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The "Hepatitis D Market - A Global and Regional Analysis: Focus on Treatment Type, Diagnostic Method, and Region - Analysis and Forecast, 2025-2035" report ...

Donald Trump claimed there's "no reason" to give a baby the hepatitis B vaccine — even it can spread from casual contact and ...

Tobevibart is an investigational broadly neutralizing monoclonal antibody targeting the hepatitis B surface antigen. It is designed to inhibit the entry of hepatitis B and hepatitis delta viruses into ...

In a press conference this week, President Trump said there's no reason to give babies the Hepatitis B vaccine. But pediatricians and infectious disease experts say this guidance is dangerous.

Hepatitis is inflammation of the liver which can be due to infection or injury. Globally at least 254 million people are living with chronic Hepatitis B and deaths from viral hepatitis now exceeds 1,2 ...

Hepatitis B, a widespread viral infection, targets the liver and can lead to chronic issues if not managed. While some clear the virus naturally, others face persistent inflammation, fibrosis, ...